$261.22 B
Share price
Change (1 day)
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Revenue for AbbVie (ABBV)

Revenue in 2023 (TTM): $55.13 B

According to AbbVie's latest financial reports the company's current revenue (TTM) is $55.13 B. In 2022 the company made a revenue of $58.05 B an increase over the years 2021 revenue that were of $56.19 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AbbVie from 2011 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$55.13 B-5.02%
2022$58.05 B3.3%
2021$56.19 B22.69%
2020$45.80 B37.69%
2019$33.26 B1.57%
2018$32.75 B16.08%
2017$28.21 B10.06%
2016$25.63 B12.16%
2015$22.85 B14.52%
2014$19.96 B6.23%
2013$18.79 B2.23%
2012$18.37 B5.36%
2011$17.44 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$68.53 B 24.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.07 B-41.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.83 B-51.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.99 B-81.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.39 B-50.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$44.93 B-18.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$44.99 B-18.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
$36.53 B-33.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.78 B-96.76%๐Ÿ‡บ๐Ÿ‡ธ USA